The cytologic examination of fine-needle aspirates and fluid specimens
is plagued by a persistent false negative rate. The rate of false neg
ative results will be decreased if sensitive molecular assays carl he
developed to detect cytologically malignant cells. The current study i
nvestigated telomerase expression as a potential marker of malignancy,
using the telomeric repeat amplification protocol (TRAP) in fine-need
le aspirates and fluid specimens. TRAP was performed on 24 fine-needle
aspirate and 24 fluid specimens from different body sites and of diff
erent histological diagnoses. We found that 6 of 12 fine-needle aspira
te specimens that were cytologically positive for malignant cells expr
essed telomerase activity, while no specimens that were cytologically
suspicions for malignancy, atypical, or negative tested positive for t
elomerase activity. Of the fluid specimens, 4 of 6 cytologically posit
ive cases and 1 of 18 cytologically negative cases expressed telomeras
e. Seven of eight telomerase negative, cytologically positive specimen
s contained only rare malignant cells in a very bloody background. Per
ipheral blood contamination is a possible pitfall in the TRAP assay, a
s applied in the current study, because the assay is standardized to p
rotein concentration that may be derived from lysed red blood cells. W
e conclude that with further technical refinement, the TRAP assay coul
d become a useful adjunct in the cytologic examination of fine-needle
aspirates and fluid samples. (C) 1998 Wiley-Liss, Inc.